Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR4 | O00206 | 1/20 | 0.50 |
| ▸ | PRKCA | P17252 | 5/20 | 0.49 |
| ▸ | AKT1 | P31749 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1705332 | 1.00 | TLR4 (0.50) | TLR4PRKCAAKT1MAPK1 | |
| SCHEMBL2198649 | 0.99 | TLR4 (0.52) | TLR4PRKCAAKT1MAPK1 | |
| SCHEMBL2297828 | 0.99 | TLR4 (0.52) | TLR4PRKCAAKT1MAPK1 | |
| SCHEMBL4856848 | 0.99 | TLR4 (0.52) | TLR4PRKCAAKT1MAPK1 | |
| SCHEMBL6290144 | 0.99 | TLR4 (0.52) | TLR4PRKCAAKT1MAPK1 | |
| SCHEMBL3875391 | 0.99 | TLR4 (0.52) | TLR4PRKCAAKT1MAPK1 | |
| SCHEMBL5425896 | 0.99 | TLR4 (0.52) | TLR4PRKCAAKT1MAPK1 | |
| SCHEMBL8145211 | 0.99 | TLR4 (0.52) | TLR4PRKCAAKT1MAPK1 | |
| SCHEMBL10325897 | 0.99 | TLR4 (0.52) | TLR4PRKCAAKT1MAPK1 | |
| SCHEMBL8144862 | 0.99 | TLR4 (0.52) | TLR4PRKCAAKT1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008102372-A1 | A COMPOSITION DERIVED FROM FENUGREEK FOR IMPROVING PHYSIOLOGY | INDUS BIOTECH PRIVATE LIMITED (IN) | 2008-08-28 | — | — | WO | disclosed |
| US-20080199517-A1 | Composition and a process thereof | INDUS BIOTECH PRIVATE LTD (IN) | 2008-08-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080199517-A1 | Composition and a process thereof | GYS1, SHBG, PYGM | TLR4 638/4885PRKCA 372/4885AKT1 995/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.